A Phase I safety and drug absorption study of a vaginal ring containing either dapivirine, maraviroc or the two antiretroviral drugs combined. The study is the first clinical trial of a vaginal ring containing maraviroc and the first to test a vaginal ring with two active drugs. It is being conducted in collaboration with the International Partnership for Microbicides.
See
15-Nov-2011
See also
